Skip to main content
. 2022 Sep 27;2022(9):CD014638. doi: 10.1002/14651858.CD014638.pub2

1.5. Analysis.

1.5

Comparison 1: Dexrazoxane versus no dexrazoxane or placebo, Outcome 5: Heart failure (i.e. clinical heart failure and subclinical myocardial dysfunction combined) available‐case